Última Hora: "Já foram publicadas as tabelas de retenção na fonte. Saiba quanto vai descontar de IRS todos os meses - ECO Economia Online" Tue, 21 Jan 2020 09:06:11 GMT    "Os cinco desafios de Rui Rio para devolver o PSD ao poder - Diário de Notícias - Lisboa" Mon, 20 Jan 2020 00:17:50 GMT    "Jovem que esfaqueou colega em Gondomar acusado de tentativa de homicídio - Jornal de Notícias" Tue, 21 Jan 2020 11:04:00 GMT    "Seis vítimas mortais e transmissão entre humanos fazem disparar receios do coronavírus - RTP" Tue, 21 Jan 2020 10:10:00 GMT    "Governo quer criar condições ?para que os jovens tenham capacidade de ter filhos mais cedo? - PÚBLICO" Tue, 21 Jan 2020 06:30:00 GMT    "Rui Tavares sentiu "vergonha alheia" com discurso de Joacine - Jornal de Notícias" Tue, 21 Jan 2020 09:54:00 GMT    "PSP condiciona entradas no aeroporto de Lisboa. Manifestação tornou-se mais ruidosa - PÚBLICO" Tue, 21 Jan 2020 10:18:00 GMT    "Vento mantém quatro distritos sob aviso amarelo - TVI24" Tue, 21 Jan 2020 06:19:00 GMT    "Condutor que matou irmã de Djaló condenado a 16 anos de prisão - A Bola" Tue, 21 Jan 2020 11:37:25 GMT   "Mais de 400. Todas as empresas em que Isabel dos Santos teve participações - Diário de Notícias - Lisboa" Tue, 21 Jan 2020 11:36:00 GMT      Para más noticias, haga clic aquí.

Zona de Acceso
       
       
¿Recordarme? 

Busque más análisis técnicos aquí en nuestro foro: Análisis Técnicos
Nota: Los datos después de 2018-12-03 son temporales y pueden tener un valor de Apertura incorrecto hasta nueva actualización...
Cambiar para Gráfico Estático de Gilead Sciences

Bajada de
--0.39 (+0.99%) Gilead Sciences - [Ticker: GILD]Gráfico Gilead Sciences  Noticias Gilead Sciences  Descargar Históricos de Metastock Gilead Sciences y Otros  Análisis Técnico Gilead Sciences  
Última Transacción71,550Hora de Cotización2018-12-03 - 00:00:00
Variación--0.39 (+0.99%)Rango 52 Semanas[0,000 - 0,000]
Máximo72,900Mínimo71,520
Volumen2.159.096Volumen Medio (3m)0
Demanda / Oferta74,800 x 800 - 74,820 x 1.000Yield
Cierre Anterior71,940PER0,00%
Apertura72,740EPS0,00
Fecha Ex-DividendoFecha Dividendo
Capitalización Bursátil0 Objetivo Estimado 1 Año0,000
Nota: Los datos pueden tener un retraso de algunos minutos.

 Noticias de Gilead Sciences [GILD]:   (ordenadas por relevancia)

Red Voltaire

¿Se esconden ensayos del Pentágono tras los crímenes de Gilead Sciences?
Red Voltaire
La firma estadounidense Gilead Sciences prosiguió deliberadamente los ensayos de su medicamente contra la hepatitis B, identificado como Sovaldi (Sofosbuvir), en violación de las normas internacionales y contra la voluntad de los pacientes.


Nasdaq

Gilead Sciences Q3 18 Earnings Conference Call At 4:30 PM ET
Nasdaq
(RTTNews.com) - Gilead Sciences Inc. ( GILD ) will host a conference call at 4:30 PM ET on October 25, 2018, to discuss Q3 18 earnings results. To access the live webcast, log on to www.gilead.com/investors. To listen to the call, dial 1-877-359-9508 ...
A Preview Of Gilead's Q3 EarningsBenzinga
Investors Are Underestimating Gilead Sciences StockInvestorplace.com
Thrashing Stocks: Gilead Sciences, Inc. (NASDAQ: GILD)News Room Alert (press release)
Fairfield Current -Wall Street Intellects (blog) -StocksNewsPro (press release)
los 105 artículos informativos »

Gilead earnings: Expect a strong quarter despite executive turnover
MarketWatch
After struggling with sluggish sales for Gilead Sciences Inc.'s core products, executives have been calling 2018 a ?trough year.? This quarter could be make or break ? and Leerink Partners analyst Geoffrey Porges is betting on the former. While many ...


NHS England and Gilead Sciences strike deal to offer patients cancer immunotherapy
Zenopa
The National Institute for Health and Care Excellence (NICE) have given the go ahead for ground breaking new therapy Yescarta (axicabtagene ciloleucel) to be made available to cancer patients who have stopped responding to treatment. Yescarta ...


Zacks.com

Will Gilead (GILD) HIV Sales Offset HCV Sales Decline in Q3?
Zacks.com
While Gilead's second-quarter results beat estimates, the year-over-year decline was disappointing as the magnitude of decline in hepatitis C virus (HCV) sales continues to deepen. Moreover, the results were overshadowed by the news of the company's ...
Gilead Sciences, Inc. (GILD) Position Trimmed by Cohen Lawrence BFairfield Current
Current Fundamentals:: Gilead Sciences, Inc., (NASDAQ: GILD)StocksNewsPro (press release)
Tough Tape Masks Gilead Sciences, Inc. (NASDAQ:GILD) Data RevealFDA Headlines
Nyse NewsToday (press release) -Post Analyst
los 114 artículos informativos »

Merck & Co. Inc. v. Gilead Sciences Inc.
SCOTUSblog (blog)
Issue: Whether the equitable defense of unclean hands precludes legal relief in the form of damages. SCOTUSblog Coverage. Petitions of the week (Aurora Barnes). Date, Proceedings and Orders (key to color coding). Jul 12 2018, Application (18A51) to ...


sharewise

Amazon, Newmont Mining, Snap, Alphabet, Baidu.com & Gilead Sciences: Diese ...
FinanzNachrichten.de
Am Donnerstag geht in Sachen US-Quartalsberichte so richtig die Post ab. Vorbörslich sorgen Celgene (WKN: 881244 / ISIN: US1510201049), Newmont Mining (WKN: 853823 / ISIN: US6516391066) und Twitter (WKN: A1W6XZ / ISIN: US90184L1026) für ...
Was sagt man dazu, Gilead Sciences?AktienCheck

los 15 artículos informativos »

Blasting News

Convegno Gilead Sciences: il 25% degli italiani soffre di fegato grasso
Blasting News
Non presenta sintomi, almeno fino a quando non si arriva ad una condizione di seria compromissione. Durante il convegno "Dopo l'HCV, le nuove emergenze per la Salute del fegato", al quale hanno preso parte medici, istituzioni e pazienti, sono stati ...
A rischio il fegato di un adulto su 4, colpa del troppo grassoANSA.it

los 23 artículos informativos »

TheStreet.com

Gilead Sciences, KeyCorp, Ventas: 'Mad Money' Lightning Round
TheStreet.com
Here's what Jim Cramer had to say about some of the stocks during the Mad Money Lightning Round: Gilead Sciences (GILD - Get Report) : "I'd hang onto this one. I think the stock is bottoming and I like it very much." KeyCorp (KEY - Get Report) : "This ...

y más »

Barron's

This Financial Giant Is Buying Up Stock in CVS, Gilead, and Alibaba ? but Dumping Netflix
Barron's
TIAA FSB, the banking unit of pension giant TIAA, late last week disclosed its holdings at the end of the third quarter in a filing with the Securities and Exchange Commission. Some investment changes it made since the end of the second quarter were ...


News-Medical.net

Gilead Sciences presents Phase 3 results of filgotinib in biologic-experienced rheumatoid arthritis at 2018 ACR/ARHP ...
News-Medical.net
Gilead Sciences, Inc. and Galapagos NV today announced detailed results from the Phase 3 FINCH 2 clinical trial of filgotinib, an investigational, selective JAK1 inhibitor, in adults with moderately-to-severely active rheumatoid arthritis and prior ...


Business Wire

UPDATE: Gilead (GILD), Galapagos NV (GLPG) Announces Positive ...
StreetInsider.com
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here. (Updated - October 22, 2018 1:21 PM EDT).
Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor ...The Lancet

los 7 artículos informativos »

Motley Fool


Gilead Sciences Is Bottoming - Cramer's Lightning Round (10/17/18)
Seeking Alpha
There's not a lot of new ones being built." The stock yields 5.7% and Cramer thinks it's a buy. Crane (NYSE:CR): It's a great American manufacturer. Let it come down a bit before buying. Gilead Sciences (NASDAQ:GILD): Hold on to it as the stock is ...


Risk-Reward With Gilead Sciences
GuruFocus.com
Gilead Sciences (NASDAQ:GILD) has been up and down a lot over the last five years. A big reason is the company's Hepatitis C drug, which had a blockbuster year in sales during 2015, only to suffer price pressure ever since. Now, that business segment ...

Para más noticias de Gilead Sciences hacer clic aquí:
Noticias de Gilead Sciences 


Anchura de la Página:

 Imagen de Fondo:

Copyright@2009-2020 - BolsaES.com, todos los derechos reservados.
Foro de Bolsa Cotizaciones Noticias de Bolsa Chat de Bolsa Disclaimer Recursos para Webmasters